Marwa G. Gazzar-El

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Design and synthesis of new curcumin analogues as hepatoprotectives and antioxidants in liver dysfunction through caspase-3 regulation.

Design and synthesis of new curcumin analogues as hepatoprotectives and antioxidants in liver dysfunction through caspase-3 regulation.

Journal: Future medicinal chemistry

Published: June 03, 2026

Ligand-Based Design of Novel Thiazole-Quinazolinone Hybrids with Dual Antimicrobial and Anti-Virulence Activity Targeting Staphylococcal Sortase A.

Ligand-Based Design of Novel Thiazole-Quinazolinone Hybrids with Dual Antimicrobial and Anti-Virulence Activity Targeting Staphylococcal Sortase A.

Journal: Bioorganic & medicinal chemistry

Published: December 19, 2025

Novel pyrrole-sulfonamide derivatives as EGFR inhibitors and radiosensitizers in lung cancer.

Novel pyrrole-sulfonamide derivatives as EGFR inhibitors and radiosensitizers in lung cancer.

Journal: Bioorganic chemistry

Published: August 16, 2025

MitoQ Mitigates Radiation-Induced Testicular Injury: Molecular Docking and Toxicity Implications.

MitoQ Mitigates Radiation-Induced Testicular Injury: Molecular Docking and Toxicity Implications.

Journal: Journal of biochemical and molecular toxicology

Published: June 18, 2025

Novel chloropyridazine sulfonamides as aromatase inhibitors and apoptotic inducers in breast cancer.

Novel chloropyridazine sulfonamides as aromatase inhibitors and apoptotic inducers in breast cancer.

Journal: Bioorganic chemistry

Published: February 18, 2025

Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers.

Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers.

Journal: Bioorganic chemistry

Published: March 04, 2024

Quinazolinone derivatives as new potential CDK4/6 inhibitors, apoptosis inducers and radiosensitizers for breast cancer.

Quinazolinone derivatives as new potential CDK4/6 inhibitors, apoptosis inducers and radiosensitizers for breast cancer.

Journal: Future medicinal chemistry

Published: August 02, 2023

Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer.

Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer.

Journal: Scientific reports

Published: December 19, 2022

Computational, in vitro and radiation-based in vivo studies on acetamide quinazolinone derivatives as new proposed purine nucleoside phosphorylase inhibitors for breast cancer.

Computational, in vitro and radiation-based in vivo studies on acetamide quinazolinone derivatives as new proposed purine nucleoside phosphorylase inhibitors for breast cancer.

Journal: European journal of medicinal chemistry

Published: August 03, 2022

Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4(3H)-ones and sulfachloropyridazine.

Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4(3H)-ones and sulfachloropyridazine.

Journal: European journal of medicinal chemistry

Published: June 29, 2022

Green synthesis of novel antifungal 1,2,4-triazoles effective against γ-irradiated Candida parapsilosis.

Green synthesis of novel antifungal 1,2,4-triazoles effective against γ-irradiated Candida parapsilosis.

Journal: Archiv der Pharmazie

Published: August 06, 2021

Anti-inflammatory and analgesic effect of LD-RT and some novel thiadiazole derivatives through COX-2 inhibition.

Anti-inflammatory and analgesic effect of LD-RT and some novel thiadiazole derivatives through COX-2 inhibition.

Journal: Archiv der Pharmazie

Published: March 28, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026